Stratrix
On the Record · Elevance Health

Elevance Health acquisitions, on the record

The businesses Elevance Health bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
Louisiana Health Service & Indemnity Company, d/b/a Blue Cross and Blue Shield of Louisiana
Word for word“On January 23, 2023, we announced our entrance into an agreement to acquire Louisiana Health Service & Indemnity Company, d/b/a Blue Cross and Blue Shield of Louisiana, an independent licensee of the BCBSA that provides healthcare plans to the Individual, Group, Medicaid and Medicare markets, primarily in the State of Louisiana.” 10-K for 2022
agreed acquisitionJanuary 23, 2023—
BioPlus Parent, LLC
Word for word“The acquisition closed on February 15, 2023, and initial purchase accounting has not been finalized.” 10-K for 2022
acquisitionFebruary 15, 2023—
Integra MLTC, Inc.
Word for word“On May 5, 2022, we completed our acquisition of Integra.” 10-K for 2022
acquisitionMay 5, 2022—
MMM Holdings, LLC
Word for word“On June 29, 2021, we completed our acquisition of MMM, including its Medicare Advantage plan, Medicaid plan and other affiliated companies.” 10-K for 2022
acquisitionJune 29, 2021—
myNEXUS, Inc.
Word for word“On April 28, 2021, we completed our acquisition of myNEXUS, Inc. (“myNEXUS”).” 10-K for 2022
acquisitionApril 28, 2021—
Paragon Healthcare, Inc.
Word for word“On January 4, 2024, we announced our entrance into an agreement to acquire Paragon Healthcare, Inc., a company providing infusion services and injectable therapies through its omnichannel model of ambulatory infusion centers, home infusion pharmacies, and other specialty pharmacy services.” 10-K for 2023
agreed acquisitionOn January 4, 2024—
Centers Plan for Healthy Living LLC and Centers for Specialty Care Group IPA, LLC
Word for word“On December 31, 2023, we entered into an agreement to acquire Centers Plan for Healthy Living LLC and Centers for Specialty Care Group IPA, LLC (“Centers”).” 10-K for 2023
agreed acquisitionOn December 31, 2023—
life and disability businesses
Word for word“On March 28, 2023, we announced our entrance into an agreement to sell our life and disability businesses to StanCorp Financial Group, Inc.” 10-K for 2023
agreed divestitureOn March 28, 2023—
BioPlus Parent, LLC and subsidiaries (“BioPlus”)
Word for word“On February 15, 2023, we completed our acquisition of BioPlus Parent, LLC and subsidiaries (“BioPlus”) from CarepathRx Aggregator, LLC.” 10-K for 2023
acquisitionOn February 15, 2023—
Centers Plan for Healthy Living LLC and Centers for Specialty Care Group IPA, LLC (“Centers”)
Word for word“On December 31, 2024, we completed our acquisition of Centers Plan for Healthy Living LLC and Centers for Specialty Care Group IPA, LLC (“Centers”).” 10-K for 2024
acquisitionDecember 31, 2024—
RSV QOZB LTSS, Inc. and certain affiliated entities (d/b/a CareBridge)
Word for word“On December 10, 2024, we completed our acquisition of RSV QOZB LTSS, Inc. and certain affiliated entities (d/b/a CareBridge), a value-based healthcare company that manages home and community-based services for Medicaid and dual-eligible Medicaid/Medicare members receiving long-term services and support.” 10-K for 2024
acquisitionDecember 10, 2024—
Paragon Healthcare, Inc. and its subsidiaries (“Paragon”)
Word for word“On March 11, 2024, we completed our acquisition of Paragon Healthcare, Inc. and its subsidiaries (“Paragon”).” 10-K for 2024
acquisitionMarch 11, 2024—
BioPlus Parent, LLC and its subsidiaries (“BioPlus”)
Word for word“On February 15, 2023, we completed our acquisition of BioPlus Parent, LLC and its subsidiaries (“BioPlus”) from CarepathRx Aggregator, LLC.” 10-K for 2024
acquisitionFebruary 15, 2023—
Paragon Healthcare, Inc. and its subsidiaries
Word for word“In addition, CarelonRx includes ambulatory infusion centers, added to our portfolio in March 2024 through our acquisition of Paragon Healthcare, Inc. and its subsidiaries.” 10-K for 2025
acquisitionMarch 2024—
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash paid for acquisitions (net of cash acquired)Cash received from selling businessesGoodwill from acquisitions
2016-12-31$0$0—
2017-12-31$2.08 billion—$1.67 billion
2018-12-31$1.76 billion—$1.28 billion
2019-12-31$0——
2020-12-31$1.98 billion——
2021-12-31$3.48 billion—$2.52 billion
2022-12-31$649 million——
2023-12-31$1.55 billion——
2024-12-31$4.81 billion——
2025-12-31−$88 million——

Deal filings since 2016

Read from Elevance Health’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023, 10-K for 2022) and the financial data it files with the SEC, as of 2026-02-06. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.